Mon, Jul 28, 2014, 1:46 AM EDT - U.S. Markets open in 7 hrs 44 mins

Recent

% | $
Click the to save as a favorite.

Celgene Corp. (CELG) Message Board

  • zevie1 zevie1 Feb 23, 1998 11:15 PM Flag

    everything depends on the fda

    it appears that at this point the main and only hope for celgene stockholders is wether the fda will approve thalomed. i've
    been following celgene for almost 2 years and i believe that any deal with basf would have happened by this time. celgene has
    been saying for thr past half a year that the basf deal is imminent.if it does happen it will end up being gravy. also, the other
    products which celgene is working on (sel cids, celgenes version of ritalin,etc) seem to be 3-5 years down the road.if the fda does
    not approve thalomid it could be a very quick road down for celgenes marketprice.on the positive side an approval by the fda
    should bring celgenes price back to the teens. let's hope for good news!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What makes you such an expert? Celgene's stock price doesn't seem to have anything to do with reality. FDA will approve any
      day (I'm being told) market is beginning to act that way and all the other stuff will just beef it up. My target is high teens
      by year end, but in a strong market & a BASF deal &/or Ritalin deal this stock can explode. Don't forget the huge off label
      sales that are not figured in to the picture. Entremed & Andrulis can only help push Celgene stock through the roof as new uses
      are discovered, & since Celgene will be the only Thalidomide player on the market for the next several years, the sales will all
      have to go through Celgene. This could push the stock into nubers we can't imagine at this point.

    • The deal with BASF will happen. But you are correct the BASF deal has been tossed around for a long time. Celgene missed the 1998 growing season so it took the sense of urgency from the deal. Don't forget up until very recently this company was madeup of mostly scientist and academics, that has changed. They also have hired a deal closer and top notch sales people.

 
CELG
87.16+0.97(+1.13%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.